Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B‐lymphocyte clones in a polyclonal population

A method has been developed to use the polymerase chain reaction to amplify and sequence the chain determining region 3 (CDR3) of the human immunoglobulin heavy‐chain gene, and to use the sequence as a marker for rare neoplastic B lymphocytes. Consensus primers for the Variable and Joining regions of the gene were constructed and shown to enable efficient amplification, directed cloning, and sequencing of CDR3. Using leukaemic cell line PFMC as a test system, CDR3 was sequenced, specific primers synthesized, and PFMC DNA was detected down to a dilution of 1:1300 in DNA from normal lymphocytes. This strategy should be useful for monitoring therapy and detecting early disease relapse in B lymphoproliferative disease.

[1]  Kevin J. Trainor,et al.  Monoclonality in B-lymphoproliferative disorders detected at the DNA level. , 1990, Blood.

[2]  C. Bartram,et al.  Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences. , 1989, Blood.

[3]  B. Lange,et al.  Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Galibert,et al.  In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias. , 1989, Leukemia.

[5]  A. Morley,et al.  Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction. , 1988, Blood.

[6]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[7]  E J Freireich,et al.  Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. , 1987, Science.

[8]  H A Erlich,et al.  Direct cloning and sequence analysis of enzymatically amplified genomic sequences. , 1986, Science.

[9]  C. Denny,et al.  A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci , 1986, Nature.

[10]  R. Levy,et al.  Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma , 1986, Cell.

[11]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[12]  D. Campana,et al.  Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. , 1985, Journal of immunology.

[13]  T. Honjo,et al.  Rearranged immunoglobulin heavy chain variable region (VH) pseudogene that deletes the second complementarity-determining region. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Tonegawa.  Somatic generation of antibody diversity , 1983, Nature.

[15]  T. Honjo,et al.  Molecular cloning and nucleotide sequencing of human immunoglobulin € chain cDNA , 1983 .

[16]  D. Givol,et al.  Evolutionary aspects of immunoglobulin heavy chain variable region (VH) gene subgroups. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M Houghton,et al.  Cloning and sequence determination of the gene for the human immunoglobulin epsilon chain expressed in a myeloma cell line. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. B. Cohen,et al.  Organization and evolution of immunoglobulin VH gene subgroups. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Hood,et al.  gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Flanagan,et al.  The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non‐allelic genes. , 1982, The EMBO journal.

[21]  Ulrich Siebenlist,et al.  Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes , 1981, Cell.

[22]  T. Rabbitts,et al.  Structure and multiplicity of genes for the human immunoglobulin heavy chain variable region. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[24]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[25]  A. Kudo,et al.  A cloned human immunoglobulin heavy chain gene with a novel direct-repeat sequence in 5' flanking region. , 1985, Gene.

[26]  T. Honjo,et al.  Molecular cloning and nucleotide sequencing of human immunoglobulin epsilon chain cDNA. , 1983, Nucleic acids research.

[27]  J. Messing.  New M13 vectors for cloning. , 1983, Methods in enzymology.

[28]  J. Messing.  [2] New M13 vectors for cloning , 1983 .

[29]  N. K. Jerne,et al.  The somatic generation of immune recognition , 1971, European journal of immunology.